Oxycodone/acetaminophen oral solution is not available from other manufacturers or in other concentrations. This shortage does not affect single-ingredient oxycodone solutions or oxycodone/acetaminophen solid oral dosage forms. Roxane discontinued oxycodone/acetaminophen 5 mL unit-dose cups in July 2014 and 500 mL bottles in April 2015. Roxane states that the reason for the shortage is that they are validating a new source for raw materials.
May 13, March 16, January 12 and 29, 2015; October 7, August 14, 2014, University of Utah, Drug Information Service. 2015, Drug Information Service, University of Utah, Salt Lake City, UT.
Acetaminophen Suppositories — Resolved Acetaminophen/dichloralphenazone/isometheptene — Resolved Alfentanil Injection — Resolved aspirin Tablets (Buffered) — Resolved Buprenorphine and Naloxone Tablets — No Longer Available Buprenorphine Injection — Resolved Buprenorphine Sublingual Tablets — Resolved Butorphanol Injection — Resolved Choline Magnesium Trisalicylate — Resolved Diazepam Injection — Resolved Diclofenac 1% Gel — Resolved Fentanyl Injection — Resolved Fentanyl Transdermal System Patch — Resolved Ketorolac Tromethamine Injection — Current Meperidine Injection — Resolved Methadone Hydrochloride Injection — Resolved Morphine Injections — Current Morphine Sulfate: Oral Concentrated Solution — Resolved Oxycodone Immediate Release Tablets and Capsules — Resolved Piroxicam Capsules — Resolved Sufentanil Injection — Current Tolmetin Sodium — Resolved.
No products are available at this time.
« Back to Drug Shortage Product Bulletins.
Roxicet Oral Solution, Roxane Laboratories Oxycodone 5 mg/Acetaminophen 325 mg per 5 mL, 500 mL (NDC Oxycodone 5 mg/Acetaminophen 325 mg per 5 mL, 500 mL (NDC - discontinued Oxycodone 5 mg/Acetaminophen 325 mg per 5 mL, 5 mL (NDC - discontinued.
ASHP is the national professional organization whose more than 43,000 members include pharmacists, student pharmacists, and pharmacy technicians who serve as patient care providers on healthcare teams in acute and ambulatory settings.
The content was prepared by the Drug Information Center of University of Utah. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin.
There are no presentations available.Oxycodone with acetaminophen